0001213900-23-029508.txt : 20230413 0001213900-23-029508.hdr.sgml : 20230413 20230413160502 ACCESSION NUMBER: 0001213900-23-029508 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230413 FILED AS OF DATE: 20230413 DATE AS OF CHANGE: 20230413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IceCure Medical Ltd. CENTRAL INDEX KEY: 0001584371 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40753 FILM NUMBER: 23818386 BUSINESS ADDRESS: STREET 1: 7 HA'ESHEL ST., POB 3163 CITY: CAESAREA STATE: L3 ZIP: 38900 BUSINESS PHONE: 972-4-6230333 MAIL ADDRESS: STREET 1: 7 HA'ESHEL ST., POB 3163 CITY: CAESAREA STATE: L3 ZIP: 38900 6-K 1 ea176909-6k_icecure.htm REPORT OF FOREIGN PRIVATE ISSUER

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2023

Commission file number: 001-40753

ICECURE MEDICAL LTD.

(Translation of registrant’s name into English)

7 Ha’Eshel St., PO Box 3163

Caesarea, 3079504 Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

CONTENTS

On April 10, 2023, IceCure Medical Ltd. (the “Company”) convened a Special General Meeting of Shareholders (the “Meeting”).

At the Meeting, a quorum was present and the shareholders of the Company voted upon and approved, by the applicable required majority, all agenda items that were described in the Company’s notice and proxy statement for the Meeting, which were included in Exhibit 99.1 to the Company’s Report of Foreign Private Issuer on Form 6-K that the Company furnished to the Securities and Exchange Commission on March 1, 2023.

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-267272) and Form S-8 (File Nos. 333-270982 and 333-262620 and File No. 333-264578), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IceCure Medical Ltd.

Date: April 13, 2023		/s/ Eyal Shamir
		Name:	Eyal Shamir
		Title:	Chief Executive Officer